Elsevier and LIPID MAPS Launch Lipid Structures App on SciVerse Applications

AMSTERDAM, December 9, 2011 /PRNewswire/ –

Application links lipid data within articles to contextual information

Elsevier [http://www.elsevier.com ], a world-leading provider of scientific, technical
and medical information products and services, today announced the availability of the
Lipid Structures (beta) [http://bit.ly/LipidsApp ] app on SciVerse Applications. The app
was developed in collaboration with LIPID MAPS, a multi-institutional consortium aimed at
increasing understanding of lipid metabolism, and the SciVerse Developer Network.

Lipid Structures (beta) identifies and links lipid names or synonyms in articles on
SciVerse ScienceDirect, providing the user with supporting information on each particular
lipid in context, such as the structure and other key information for that molecule as
represented on the LIPID MAPS(TM) website [http://www.lipidmaps.org ]. Information
includes common and systematic names, formula, exact mass, InChIKey, classification
hierarchy and links to other public databases. A panel in the side-bar also provides a
convenient listing of lipid molecules in the article along with the number of occurrences
within the article text. The application draws on the LIPID MAPS Structure Database
(LMSD), a relational database encompassing structures and annotations of biologically
relevant lipids with over 30,000 unique lipid structures.

“The LIPID MAPS consortium is pleased to collaborate with Elsevier in using the Lipid
Structures (beta) application to deliver online content for this important class of
biomolecules,” said Eoin Fahy, LIPID MAPS Bioinformatics Project Coordinator. “We believe
this application will provide a very convenient interactive source of information on lipid
structure, classification and properties, and hopefully will serve as a useful reference
and educational tool for the lipidomics community.”

“Elsevier’s application framework enables us to collaborate with organizations like
LIPID MAPS to rapidly create deep interoperability between articles and databases via
entity linking in the full text,” said Rafael Sidi, Vice President, Application
Marketplace and Developer Network at Elsevier. “Applications which support these
connections with key domain specific resources represent a new frontier in scientific
search and discovery tools, and we hope this is the first of many to come.”

SciVerse Applications [http://www.applications.sciverse.com ] and the Developer
Network [http://developers.sciverse.com ] provide opportunities for researchers and
librarians to collaborate with developers in creating and promoting new applications that
improve research workflows. The Developer Network features a growing community of
application developers that gain potential recognition, prestige and revenue through their
contributions to SciVerse Applications.

About LIPID MAPS Structure Database (LMSD)

The LIPID MAPS Structure Database (LMSD) is a relational database encompassing
structures and annotations of biologically relevant lipids. It contains over 30,000 unique
lipid structures, making it the largest public lipid-only database in the world.
Structures of lipids in the database come from several sources: (i) LIPID MAPS
Consortium’s core laboratories and partners; (ii) lipids identified by LIPID MAPS
experiments; (iii) biologically relevant lipids manually curated from LIPID BANK, LIPIDAT,
Lipid Library, Cyberlipids, ChEBI and other public sources; (iv) novel lipids submitted to
peer-reviewed journals; (v) computationally generated structures for appropriate classes.

All the lipid structures in LMSD adhere to the structure drawing rules proposed by the
LIPID MAPS consortium. Additionally, all lipids in the LMSD have been classified using the
LIPID MAPS Lipid Classification System, and each lipid structure has been assigned a LIPID
MAPS ID (LM_ID) which reflects its position in the classification hierarchy.

About LIPID MAPS

The LIPID MAPS (Lipid Metabolites and Pathways Strategy) consortium is a
multi-institutional effort to further our understanding of lipid metabolism and the role
lipids play in diseases such as diabetes, stroke, and cancer. The consortium takes a
systems biology approach using the mouse macrophage as a model system, and provides tools
and resources for the wider community. The ultimate goal of the LIPID MAPS effort is to
better understand lipid metabolism and the active role lipids play in diabetes, stroke,
cancer, arthritis, Alzheimer’s and other lipid-based diseases in order to facilitate
development of more effective treatments.

About the Elsevier SciVerse Suite

The SciVerse [http://www.hub.sciverse.com/action/home ] suite of search and discovery
offerings provides the global research community access to a constantly expanding universe
of content and solutions which can now be accessed in one platform. The suite currently
includes SciVerse ScienceDirect [http://www.sciencedirect.com ], the world’s largest
source of peer-reviewed content containing more than 10 million articles, and SciVerse
Scopus [http://www.scopus.com/home.url ], an abstract and citation database containing 41
million records, 70% with abstracts and nearly 19,500 titles from 5,000 publishers
worldwide. The platform also includes SciVerse Hub
[http://www.hub.sciverse.com/action/home ] beta, which enables researchers to perform a
single search across all of the SciVerse content as well as targeted web content with
results ranked by relevancy and without duplication. SciVerse Applications
[http://www.applications.sciverse.com/action/userhome ] and Developer Network
[http://www.developers.sciverse.com ] allow the scientific community to build, find and
use applications that enhance the SciVerse research experience.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and close to 20,000 book
titles, including major reference works from Mosby and Saunders. Elsevier’s online
solutions include SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult [http://www.nursingconsult.com ], which
enhance the productivity of science and health professionals, and the SciVal suite
[http://www.scival.com ] and MEDai’s Pinpoint Review [http://www.medai.com ], which help
research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world-leading publisher and information provider, which
is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN
(Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Will DeGirolamo
        wdegirolamon@psbpr.com
        +1-212-752-8338

SOURCE Elsevier